Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  CSL Limited    CSL   AU000000CSL8

CSL LIMITED (CSL)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Securities Exc…
12/07/2017 12/08/2017 12/11/2017 12/12/2017 12/13/2017 Date
142.15(c) 142.03(c) 141.43(c) 140.61(c) 141.53 Last
633 099 1 100 333 510 490 579 522 552 990 Volume
+0.54% -0.08% -0.42% -0.58% +0.65% Change
More quotes
Financials ($)
Sales 2018 7 424 M
EBIT 2018 2 093 M
Net income 2018 1 586 M
Debt 2018 3 472 M
Yield 2018 1,46%
Sales 2019 8 094 M
EBIT 2019 2 393 M
Net income 2019 1 830 M
Debt 2019 3 222 M
Yield 2019 1,62%
P/E ratio 2018 30,67
P/E ratio 2019 26,70
EV / Sales2018 6,91x
EV / Sales2019 6,31x
Capitalization 47 848 M
More Financials
Company
CSL Ltd. is a biopharmaceutical company.It engages in researches, develops, manufactures and markets vaccines and plasma protein biotherapies to treat and prevent human medical conditions.The company operates its business through two segments: CSL Behring and bioCSL.The CSL Behring segment provides... 
Sector
Pharmaceuticals
Calendar
02/14Earnings Release
More about the company
Surperformance© ratings of CSL Limited
Trading Rating : Investor Rating :
More Ratings
Latest news on CSL LIMITED
12/12 CSL : Appoints New Directors
12/06 CSL : Expansion of CSL Biotech Facility Drives Advanced Manufacturing Growth and..
12/04 CSL : and Vitaeris Announce Strategic Partnership with Option to Acquire
12/04 CSL : Confirms Phase 3 Clinical Trial of New Therapy for Heart Attack Survivors
11/16 CSL : Lancet Neurology Publishes Results from CSL Behring Phase III Study of Hiz..
11/13 CSL : Major UK investment to boost influenza vaccine production, jobs and export..
10/27 CSL : Behring - New Data for HAEGARDA to be presented at the 2017 American Colle..
10/16 CSL : Australian Scientists awarded $2.5m to support ground-breaking medical res..
10/16 CSL : Behring Trains Employees to Save Lives in Their Communities and Workplace ..
10/13 CSL : Federal Contracts Awarded by Federal Agencies in Minnesota (Oct. 13)
More news
Sector news : Biopharmaceuticals
04:46a REGENERON PHARMACEUTICALS : France's Sanofi pins hopes on new drugs after setbac..
04:09aDJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
03:55aDJSANOFI : to Begin at Least 10 Phase 3 Studies Over Next 12 Months
12:47a SANOFI : Did Sanofi, WHO ignore warning signals on dengue vaccine?
12/12 Sanofi investors hungry for drug progress and deal news
More sector news : Biopharmaceuticals
News from SeekingAlpha
10/18 CSL (CSLLY) Investor Presentation - Slideshow
08/22 CSL Limited Leader In High Growth Plasma Sales To China
08/10 CSL reports Q2 results
06/13 CSL (CMXHF) Acquires Wuhan Zhong Yuan Rui De Biological Products - Slideshow
2016 EWA : Getting In Down Under
Chart CSL LIMITED
Duration : Period :
CSL Limited Technical Analysis Chart | CSL | AU000000CSL8 | 4-Traders
Technical analysis trends CSL LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 111 $
Spread / Average Target 4,8%
EPS Revisions
Managers
NameTitle
Paul Roger Perreault Chief Executive Officer, Executive Director & MD
John Shine Chairman
David Mark Lamont Chief Financial Officer
Andrew Cuthbertson Chief Scientific Officer
David Westbrook Anstice Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSL LIMITED41.45%47 999
BIOGEN22.28%69 371
ALEXION PHARMACEUTICALS-12.73%25 000
GRIFOLS SA27.54%17 919
BIOMARIN PHARMACEUTICAL-2.34%15 474
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%7 253